Gradient Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Sell
3,723
-48
-1% -$5.62K 0.01% 373
2026
Q1
$454K Sell
3,771
-18
-0.5% -$2.08K 0.01% 358
2025
Q4
$399K Sell
3,789
-371
-9% -$34.8K 0.01% 288
2025
Q3
$349K Sell
4,160
-474
-10% -$39K 0.01% 322
2025
Q2
$367K Buy
4,634
+403
+10% +$32K 0.01% 308
2025
Q1
$380K Buy
4,231
+100
+2% +$9.34K 0.01% 266
2024
Q4
$411K Sell
4,131
-289
-7% -$29.8K 0.01% 248
2024
Q3
$502K Sell
4,420
-1,191
-21% -$141K 0.01% 233
2024
Q2
$695K Buy
5,611
+1,634
+41% +$210K 0.02% 205
2024
Q1
$525K Sell
3,977
-3,539
-47% -$436K 0.01% 216
2023
Q4
$819K Sell
7,516
-85
-1% -$8.82K 0.02% 200
2023
Q3
$782K Sell
7,601
-1,023
-12% -$110K 0.02% 186
2023
Q2
$995K Buy
8,624
+303
+4% +$34.4K 0.03% 178
2023
Q1
$885K Sell
8,321
-241
-3% -$26K 0.02% 179
2022
Q4
$950K Sell
8,562
-1,540
-15% -$157K 0.03% 185
2022
Q3
$870K Buy
10,102
+177
+2% +$15.8K 0.03% 185
2022
Q2
$905K Buy
9,925
+123
+1% +$10.9K 0.03% 184
2022
Q1
$804K Sell
9,802
-27,315
-74% -$2.15M 0.02% 186
2021
Q4
$2.85M Sell
37,117
-122,083
-77% -$9.72M 0.07% 150
2021
Q3
$12M Buy
159,200
+7,624
+5% +$580K 0.34% 81
2021
Q2
$11.8M Buy
151,576
+1,907
+1% +$142K 0.34% 79
2021
Q1
$11M Sell
149,669
-23,821
-14% -$1.76M 0.36% 74
2020
Q4
$13.7M Sell
173,490
-1,872
-1% -$143K 0.58% 41
2020
Q3
$13.9M Buy
175,362
+17,242
+11% +$1.35M 0.58% 41
2020
Q2
$11.7M Buy
158,120
+529
+0.3% +$39.8K 0.53% 49
2020
Q1
$11.6M Buy
157,591
+13,026
+9% +$1.02M 0.62% 33
2019
Q4
$12.5M Buy
144,565
+6,547
+5% +$538K 0.56% 43
2019
Q3
$11.1M Buy
138,018
+114,525
+487% +$9.18M 0.54% 42
2019
Q2
$1.88M Buy
23,493
+15,271
+186% +$1.17M 0.1% 122
2019
Q1
$652K Sell
8,222
-125,112
-94% -$9.36M 0.04% 164
2018
Q4
$9.72M Sell
133,334
-28,083
-17% -$1.98M 0.58% 24
2018
Q3
$10.9M Sell
161,417
-2,478
-2% -$158K 0.56% 26
2018
Q2
$9.49M Buy
163,895
+6,161
+4% +$348K 0.51% 31
2018
Q1
$8.2M Buy
157,734
+153,573
+3,691% +$8.29M 0.44% 60
2017
Q4
$223K Buy
+4,161
New +$231K 0.01% 240
2017
Q3
Sell
-2,840
Closed -$174K 529
2017
Q2
$174K Buy
2,840
+423
+18% +$25.7K 0.01% 226
2017
Q1
$147K Buy
2,417
+707
+41% +$42.9K 0.01% 237
2016
Q4
$96K Sell
1,710
-463
-21% -$27.1K 0.01% 214
2016
Q3
$129K Sell
2,173
-77,157
-97% -$4.51M 0.01% 200
2016
Q2
$4.36M Buy
79,330
+8,041
+11% +$428K 0.47% 54
2016
Q1
$3.6M Buy
71,289
+2,527
+4% +$124K 0.44% 70
2015
Q4
$3.47M Buy
68,762
+3,963
+6% +$200K 0.46% 61
2015
Q3
$3.05M Sell
64,799
-3,536
-5% -$188K 0.43% 70
2015
Q2
$3.71M Buy
68,335
+3,777
+6% +$212K 0.51% 49
2015
Q1
$3.54M Buy
64,558
+4,996
+8% +$283K 0.53% 54
2014
Q4
$3.23M Buy
59,562
+6,936
+13% +$386K 0.53% 59
2014
Q3
$2.98M Buy
52,626
+3,984
+8% +$224K 0.54% 36
2014
Q2
$2.69M Buy
48,642
+4,725
+11% +$258K 0.53% 38
2014
Q1
$2.38M Buy
43,917
+3,794
+9% +$196K 0.55% 28
2013
Q4
$1.92M Buy
40,123
+5,860
+17% +$268K 0.51% 38
2013
Q3
$1.56M Buy
34,263
+5,514
+19% +$252K 0.49% 41
2013
Q2
$1.27M Buy
+28,749
New +$1.28M 0.48% 42

Other funds holding MRK

Gradient Investments's MRK Position: Q2 2026 in Review

Gradient Investments reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $5.62K and leaving 3,723 shares worth $478K. The position accounts for 0.01% of the portfolio, ranked #373.

Gradient Investments first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q3 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gradient Investments held 3,723 shares of Merck worth $478K as of Q2 2026.
  • Gradient Investments sold 48 Merck shares in Q2 2026, an estimated $5.62K.
  • Merck made up 0.01% of Gradient Investments's portfolio in Q2 2026, its #373 holding.
  • Gradient Investments first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Gradient Investments's Merck position peaked at $13.9M in Q3 2020.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.